Addiction Medicine Grand Rounds: "Novel Approaches to Buprenorphine Extended-Release and Methadone Initiation and Alpha-2 Agonist Withdrawal Management"

The Yale Program in Addiction Medicine is pleased to welcome Pouya Azar MD, as guest speaker for Addiction Medicine Grand Rounds on March 24, 2026.

This event will be held in a virtual format.

Title: Novel Approaches to Buprenorphine Extended-Release and Methadone Initiation and Alpha-2 Agonist Withdrawal Management

Learning Objectives:

1. Describe the unique pharmacology of high-potency synthetic opioids and novel non-opioid adulterants in the unregulated drug supply and their implications for initiating medications for opioid use disorder.
2. Discuss the evidence base, pharmacologic rationale, clinical applications, and relative risks and benefits of novel approaches to initiate buprenorphine extended-release and methadone.
3. Discuss the evidence base, pharmacologic rationale, and clinical applications of novel approaches to alpha-2 agonist withdrawal management.

Addiction Medicine Rounds are CME accredited. Each session will be assigned 1 AMA PRA Category 1 CreditsTM